|
JPS6041077B2
(ja)
|
1976-09-06 |
1985-09-13 |
喜徳 喜谷 |
1,2‐ジアミノシクロヘキサン異性体のシス白金(2)錯体
|
|
US4261989A
(en)
|
1979-02-19 |
1981-04-14 |
Kaken Chemical Co. Ltd. |
Geldanamycin derivatives and antitumor drug
|
|
US5266573A
(en)
|
1989-08-07 |
1993-11-30 |
Elf Sanofi |
Trifluoromethylphenyltetrahydropyridines for the treatment and/or prophylaxis of intestinal motility disorders
|
|
EP0647450A1
(en)
|
1993-09-09 |
1995-04-12 |
BEHRINGWERKE Aktiengesellschaft |
Improved prodrugs for enzyme mediated activation
|
|
ATE446955T1
(de)
|
1995-03-30 |
2009-11-15 |
Pfizer Prod Inc |
Chinazolinone derivate
|
|
US5763263A
(en)
|
1995-11-27 |
1998-06-09 |
Dehlinger; Peter J. |
Method and apparatus for producing position addressable combinatorial libraries
|
|
CN100503580C
(zh)
|
1996-04-12 |
2009-06-24 |
沃尼尔·朗伯公司 |
酪氨酸激酶的不可逆抑制剂
|
|
ZA986732B
(en)
*
|
1997-07-29 |
1999-02-02 |
Warner Lambert Co |
Irreversible inhibitiors of tyrosine kinases
|
|
TW436485B
(en)
|
1997-08-01 |
2001-05-28 |
American Cyanamid Co |
Substituted quinazoline derivatives
|
|
UA71945C2
(en)
|
1999-01-27 |
2005-01-17 |
Pfizer Prod Inc |
Substituted bicyclic derivatives being used as anticancer agents
|
|
JP3270834B2
(ja)
|
1999-01-27 |
2002-04-02 |
ファイザー・プロダクツ・インク |
抗がん剤として有用なヘテロ芳香族二環式誘導体
|
|
EE05345B1
(et)
|
1999-02-10 |
2010-10-15 |
Astrazeneca Ab |
Kinasoliini derivaadid angiogeneesi inhibiitoritena
|
|
NZ516633A
(en)
|
1999-06-21 |
2004-09-24 |
Boehringer Ingelheim Pharma |
Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof
|
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
|
GB0018891D0
(en)
|
2000-08-01 |
2000-09-20 |
Novartis Ag |
Organic compounds
|
|
DE50111799D1
(de)
|
2000-04-08 |
2007-02-15 |
Boehringer Ingelheim Pharma |
Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
|
DE10042061A1
(de)
|
2000-08-26 |
2002-03-07 |
Boehringer Ingelheim Pharma |
Bicyclische Heterocyclen,diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
|
KR100600550B1
(ko)
|
2000-10-20 |
2006-07-13 |
에자이 가부시키가이샤 |
질소 함유 방향환 유도체
|
|
DE10063435A1
(de)
|
2000-12-20 |
2002-07-04 |
Boehringer Ingelheim Pharma |
Chinazolinderviate,diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
|
US6995162B2
(en)
|
2001-01-12 |
2006-02-07 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
|
DE60223279T2
(de)
|
2001-11-30 |
2008-05-29 |
Osi Pharmaceuticals, Inc. |
Verfahren für die herstellung substituierter bicyclischer derivate zur behandlung von anomalem zellwachstum
|
|
EP1478648B1
(en)
|
2002-02-01 |
2014-04-30 |
ARIAD Pharmaceuticals, Inc. |
Phosphorus-containing compounds and uses thereof
|
|
RU2312861C2
(ru)
|
2002-03-05 |
2007-12-20 |
Мерк Фросст Кэнада Лтд. |
Ингибиторы катепсин-цистеинпротеазы
|
|
DE10217689A1
(de)
|
2002-04-19 |
2003-11-13 |
Boehringer Ingelheim Pharma |
Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, ihre Verwendung und Verfahren zu ihrer Herstellung
|
|
TWI275390B
(en)
|
2002-04-30 |
2007-03-11 |
Wyeth Corp |
Process for the preparation of 7-substituted-3- quinolinecarbonitriles
|
|
PE20040945A1
(es)
|
2003-02-05 |
2004-12-14 |
Warner Lambert Co |
Preparacion de quinazolinas substituidas
|
|
US7399865B2
(en)
|
2003-09-15 |
2008-07-15 |
Wyeth |
Protein tyrosine kinase enzyme inhibitors
|
|
BRPI0414488A
(pt)
|
2003-09-16 |
2006-11-14 |
Astrazeneca Ab |
derivado de quinazolina, composição farmacêutica, uso de um derivado de quinazolina, métodos para produzir um efeito anti - proliferativo em um animal de sangue quente, para prevenção ou tratamento de tumores em um aminal de sangue quente, para fornecer um efeito inibidor da tirosina quinase de egfr seletivo em um animal de sangue quente e para tratar um cáncer em um animal de sangue quente e, processo para a preparação de um derivado de quinazolina
|
|
HRP20110958T1
(hr)
|
2004-05-06 |
2012-01-31 |
Warner-Lambert Company Llc |
4-fenilaminokinazolin-6-ilamidi
|
|
WO2006028958A2
(en)
|
2004-09-02 |
2006-03-16 |
Genentech, Inc. |
Pyridyl inhibitors of hedgehog signalling
|
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
|
PE20070207A1
(es)
|
2005-07-22 |
2007-03-09 |
Genentech Inc |
Tratamiento combinado de los tumores que expresan el her
|
|
WO2007055513A1
(en)
|
2005-11-08 |
2007-05-18 |
Hanmi Pharm. Co., Ltd. |
Quinazoline derivatives as a signal transduction inhibitor and method for the preparation thereof
|
|
CA2662617C
(en)
|
2006-09-11 |
2014-11-18 |
Changgeng Qian |
Quinazoline based egfr inhibitors containing a zinc binding moiety
|
|
TWI377944B
(en)
|
2007-06-05 |
2012-12-01 |
Hanmi Holdings Co Ltd |
Novel amide derivative for inhibiting the growth of cancer cells
|
|
BRPI0816769A2
(pt)
|
2007-09-12 |
2016-11-29 |
Hoffmann La Roche |
combinações de compostos inibidores de fosfoinositida 3-cinase e agentes quimioterapêuticos, e métodos de uso
|
|
WO2009055730A1
(en)
|
2007-10-25 |
2009-04-30 |
Genentech, Inc. |
Process for making thienopyrimidine compounds
|
|
US8168784B2
(en)
|
2008-06-20 |
2012-05-01 |
Abbott Laboratories |
Processes to make apoptosis promoters
|
|
US9006252B2
(en)
|
2008-09-26 |
2015-04-14 |
National Health Research Institutes |
Fused multicyclic compounds as protein kinase inhibitors
|
|
US8735409B2
(en)
*
|
2009-12-21 |
2014-05-27 |
Qiang Zhang |
Quinazoline derivatives
|
|
CN102382106A
(zh)
|
2010-08-30 |
2012-03-21 |
黄振华 |
苯胺取代的喹唑啉衍生物
|
|
CN102382065B
(zh)
|
2010-08-30 |
2014-05-28 |
山东轩竹医药科技有限公司 |
苯胺取代的喹唑啉衍生物
|
|
CN102452989B
(zh)
|
2010-10-19 |
2014-10-22 |
山东轩竹医药科技有限公司 |
苯胺取代的喹唑啉衍生物
|
|
EP2680850B1
(en)
|
2011-03-04 |
2018-05-23 |
Newgen Therapeutics, Inc. |
Alkyne substituted quinazoline compound and methods of use
|
|
CN102731485B
(zh)
|
2011-04-02 |
2016-06-15 |
齐鲁制药有限公司 |
4-(取代苯氨基)喹唑啉衍生物及其制备方法、药物组合物和用途
|
|
CN102898386B
(zh)
|
2011-07-27 |
2015-07-29 |
上海医药集团股份有限公司 |
喹唑啉衍生物、其制备方法、中间体、组合物及其应用
|
|
CN103987700B
(zh)
|
2012-03-09 |
2016-08-31 |
江苏豪森药业集团有限公司 |
4-喹唑啉胺类衍生物及其用途
|
|
WO2013173254A1
(en)
*
|
2012-05-14 |
2013-11-21 |
Dawei Zhang |
Bicyclic compounds as kinases inhibitors
|
|
CN103965120B
(zh)
*
|
2013-01-25 |
2016-08-17 |
上海医药集团股份有限公司 |
喹啉及喹唑啉衍生物、制备方法、中间体、组合物及应用
|
|
CN104119350B
(zh)
*
|
2013-04-28 |
2017-04-12 |
广东东阳光药业有限公司 |
氨基喹唑啉类衍生物及其盐和使用方法
|
|
CN104513229A
(zh)
|
2013-09-28 |
2015-04-15 |
正大天晴药业集团股份有限公司 |
喹唑啉衍生物及其制备方法
|
|
MX380928B
(es)
|
2013-10-10 |
2025-03-12 |
Araxes Pharma Llc |
Inhibidores de kras g12c.
|
|
WO2016023217A1
(zh)
|
2014-08-15 |
2016-02-18 |
安润医药科技(苏州)有限公司 |
喹唑啉衍生物、其制备方法、药物组合物和应用
|
|
WO2016055982A1
(en)
*
|
2014-10-10 |
2016-04-14 |
Acerta Pharma B.V. |
Quinoline and quinazoline compounds
|
|
WO2020068867A1
(en)
*
|
2018-09-25 |
2020-04-02 |
Black Diamond Therapeutics, Inc. |
Quinazoline derivatives as tyrosine kinase inhibitor, compositions, methods of making them and their use
|